Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Sanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color

Ruchika Sharma9 Jun 2025 1:12 PM IST

Paris: Sanofi has announced that results from the DISCOVER phase 4, single-arm, open-label study assessing Dupixent (dupilumab) in adults and...

Bayer, Broad Institute extend research collaboration to develop new cardiovascular therapies

Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Bayer

Ruchika Sharma9 Jun 2025 10:00 AM IST

Berlin: Bayer has announced results of the Phase II CONFIDENCE study, demonstrating that simultaneous initiation of finerenone (Kerendia)...

Banned medicated soap found in Karimnagar medical shop raid

Ruchika Sharma8 Jun 2025 4:15 PM IST

Telangana: Drugs Control Administration, Telangana, has seized a banned drug, 'Medicated Skin Care Soap containing Permethrin IP 1.0%, Cetrimide IP...

Sanofi launches 2025 Global Employee Stock Purchase Plan

Ruchika Sharma8 Jun 2025 12:30 PM IST

Paris: Sanofi's global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries.In 2024 alone,...

CDSCO Panel Approves Bayers Real-World Use Study for Heart Failure Drug Vericiguat

Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor

Ruchika Sharma8 Jun 2025 10:00 AM IST

San Diego: Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of...

Lupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER

Ruchika Sharma7 Jun 2025 5:24 PM IST

Mumbai: Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for...

Eye condition NAION is a very rare side effect of semaglutide: EMA safety committee

EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy

Ruchika Sharma7 Jun 2025 4:52 PM IST

European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns...

Wockhardt seeks DCGI nod for Zaynich

Ruchika Sharma7 Jun 2025 3:33 PM IST

Drugmaker Wockhardt on Friday said that it has filed for regulatory approval of its Zaynich with the Drug Controller General of India (DCGI),...

Reckitt names Ravi B as Director Corporate Communications and Corporate Affairs ( South Asia, MENARP and Africa)

Reckitt names Ravi Bhatnagar as Director Corporate Communications and Corporate Affairs (South Asia, MENARP and Africa)

Ruchika Sharma7 Jun 2025 2:38 PM IST

Reckitt has appointed Ravi Bhatnagar as its new Director of Corporate Communications and Corporate Affairs for South Asia, MENARP, and...

Suspected spurious drugs worth Rs 5.21 lakh seized in Telangana

Suspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad

Ruchika Sharma6 Jun 2025 5:30 PM IST

Telangana: In a raid conducted at the residence of a habitual offender in Hyderabad, the Drugs Control Administration, Telangana has...

Zydus gets USFDA EIR for Ankleshwar API facility

Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million

Ruchika Sharma6 Jun 2025 3:05 PM IST

Pennington: Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences Limited, has entered into Securities Purchase...

AstraZeneca Calquence based regimens approved in EU for previously untreated chronic lymphocytic leukaemia

Ruchika Sharma6 Jun 2025 12:28 PM IST

A fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, has received...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok